omniture
logo
Search
PHASE SCIENTIFIC INTERNATIONAL LIMITED
Media Room

Latest News

rss

INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ -- PHASE Scientific International, LTD

2022-03-23 00:00 2574

Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control

HONG KONG and SINGAPORE, Jan. 26, 2022 /PRNewswire/ -- PHASE Scientific International LTD

2022-01-26 17:18 3757
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control

Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control

HONG KONG, Jan. 26, 2022 /PRNewswire/ -- PHASE Scientific International LTD

2022-01-26 17:15 3442
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control

Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test

HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its  INDICAID™ COVID-19 Rap...

2021-08-30 09:00 4975

INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration

HONG KONG and GARDEN GROVE, Calif., Aug. 11, 2021 /PRNewswire/ -- PHASE Scientific International LT...

2021-08-11 01:00 4749
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration

INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization from the U.S. Food and Drug Administration

GARDEN GROVE, Calif., Aug. 10, 2021 /PRNewswire/ -- PHASE Scientific International LTD

2021-08-10 22:00 2622
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization from the U.S. Food and Drug Administration